Anti-osteoporotic treatment reduces risk of revision following total shoulder arthroplasty in patients with osteoporosis
Authors:
- Philip M. ParelPPPhilip M. Parel
- Emile-Victor KuylEKEmile-Victor Kuyl
- Mark HaftMHMark Haft
- Rachel SilvermanRSRachel Silverman
- Abhisri RameshARAbhisri Ramesh
- Amil R. AgarwalAAAmil R. Agarwal
- Theodore QuanTQTheodore Quan
- Rachel A. RansonRRRachel A. Ranson
- Zachary R. ZimmerZZZachary R. Zimmer
- Uma SrikumaranUSUma Srikumaran
- 12 November 2024
- journal article
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 34 (6) , e348-e354
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysisArchives of Osteoporosis, 2023
- Trends in anti-osteoporotic medication utilization following fragility fracture in the USA from 2011 to 2019Osteoporosis International, 2022
- Total Joint Arthroplasty and Osteoporosis: Looking Beyond the Joint to Bone HealthThe Journal of Arthroplasty, 2022
- Bisphosphonates in Total Joint Arthroplasty: A Review of Their Use and ComplicationsArthroplasty Today, 2022
- Osteoporosis Is Common and Undertreated Prior to Total Joint ArthroplastyThe Journal of Arthroplasty, 2019
- The use of bisphosphonates after joint arthroplasty is associated with lower implant revision rateKnee Surgery, Sports Traumatology, Arthroscopy, 2018
- Lower Total Knee Arthroplasty Revision Risk Associated With Bisphosphonate Use, Even in Patients With Normal Bone DensityThe Journal of Arthroplasty, 2016
- Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement RegistryClinical Orthopaedics and Related Research, 2015
- The Epidemiology of Revision Total Knee Arthroplasty in the United StatesClinical Orthopaedics and Related Research, 2010
- Infection Associated With Hematoma Formation After Shoulder ArthroplastyClinical Orthopaedics and Related Research, 2008